Literature DB >> 26432818

Review of the neutrophil response to Bordetella pertussis infection.

Joshua C Eby1, Casandra L Hoffman2, Laura A Gonyar2, Erik L Hewlett2.   

Abstract

The nature and timing of the neutrophil response to infection with Bordetella pertussis is influenced by multiple virulence factors expressed by the bacterium. After inoculation of the host airway, the recruitment of neutrophils signaled by B. pertussis lipooligosaccharide (LOS) is suppressed by pertussis toxin (PTX). Over the next week, the combined activities of PTX, LOS and adenylate cyclase toxin (ACT) result in production of cytokines that generate an IL-17 response, promoting neutrophil recruitment which peaks at 10-14 days after inoculation in mice. Arriving at the site of infection, neutrophils encounter the powerful local inhibitory activity of ACT, in conjunction with filamentous hemagglutinin. With the help of antibodies, neutrophils contribute to clearance of B. pertussis, but only after 28-35 days in a naïve mouse. Studies of the lasting, antigen-specific IL-17 response to infection in mice and baboons has led to progress in vaccine development and understanding of pathogenesis. Questions remain about the mediators that coordinate neutrophil recruitment and the mechanisms by which neutrophils overcome B. pertussis virulence factors. © FEMS 2015. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Bordetella pertussis; IL-17; neutrophil; toxin; vaccine

Mesh:

Substances:

Year:  2015        PMID: 26432818      PMCID: PMC4626575          DOI: 10.1093/femspd/ftv081

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.951


  96 in total

1.  Recognition of a bacterial adhesion by an integrin: macrophage CR3 (alpha M beta 2, CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis.

Authors:  D Relman; E Tuomanen; S Falkow; D T Golenbock; K Saukkonen; S D Wright
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

2.  Effect of tracheal cytotoxin from Bordetella pertussis on human neutrophil function in vitro.

Authors:  D R Cundell; K Kanthakumar; G W Taylor; W E Goldman; T Flak; P J Cole; R Wilson
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

3.  Pertactin is required for Bordetella species to resist neutrophil-mediated clearance.

Authors:  Carol S Inatsuka; Qian Xu; Ivan Vujkovic-Cvijin; Sandy Wong; Scott Stibitz; Jeff F Miller; Peggy A Cotter
Journal:  Infect Immun       Date:  2010-04-26       Impact factor: 3.441

4.  Substitution of the Bordetella pertussis lipid A phosphate groups with glucosamine is required for robust NF-kappaB activation and release of proinflammatory cytokines in cells expressing human but not murine Toll-like receptor 4-MD-2-CD14.

Authors:  Nico Marr; Adeline M Hajjar; Nita R Shah; Alexey Novikov; Cathy S Yam; Martine Caroff; Rachel C Fernandez
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

Review 5.  Innate IL-17-producing cells: the sentinels of the immune system.

Authors:  Daniel J Cua; Cristina M Tato
Journal:  Nat Rev Immunol       Date:  2010-06-18       Impact factor: 53.106

6.  Cocapping of the leukoadhesin molecules complement receptor type 3 and lymphocyte function-associated antigen-1 with Fc gamma receptor III on human neutrophils. Possible role of lectin-like interactions.

Authors:  M Zhou; R F Todd; J G van de Winkel; H R Petty
Journal:  J Immunol       Date:  1993-04-01       Impact factor: 5.422

7.  Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model.

Authors:  K H Mills; A Barnard; J Watkins; K Redhead
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

8.  Pertussis toxin-sensitive factor differentially regulates lipopolysaccharide-induced tumor necrosis factor-alpha and nitric oxide production in mouse peritoneal macrophages.

Authors:  X Zhang; D C Morrison
Journal:  J Immunol       Date:  1993-02-01       Impact factor: 5.422

9.  Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization.

Authors:  K Saukkonen; C Cabellos; M Burroughs; S Prasad; E Tuomanen
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

10.  Bordetella pertussis filamentous hemagglutinin interacts with a leukocyte signal transduction complex and stimulates bacterial adherence to monocyte CR3 (CD11b/CD18).

Authors:  Y Ishibashi; S Claus; D A Relman
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more
  16 in total

1.  Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans.

Authors:  Ang Lin; Danijela Apostolovic; Maja Jahnmatz; Frank Liang; Sebastian Ols; Teghesti Tecleab; Chenyan Wu; Marianne van Hage; Ken Solovay; Keith Rubin; Camille Locht; Rigmor Thorstensson; Marcel Thalen; Karin Loré
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

2.  Albumin, in the Presence of Calcium, Elicits a Massive Increase in Extracellular Bordetella Adenylate Cyclase Toxin.

Authors:  Laura A Gonyar; Mary C Gray; Gregory J Christianson; Borna Mehrad; Erik L Hewlett
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

3.  Pertussis toxin suppresses dendritic cell-mediated delivery of B. pertussis into lung-draining lymph nodes.

Authors:  Nela Klimova; Jana Holubova; Gaia Streparola; Jakub Tomala; Ludmila Brazdilova; Ondrej Stanek; Ladislav Bumba; Peter Sebo
Journal:  PLoS Pathog       Date:  2022-06-06       Impact factor: 7.464

Review 4.  Bacterial Toxins as Pathogen Weapons Against Phagocytes.

Authors:  Ana do Vale; Didier Cabanes; Sandra Sousa
Journal:  Front Microbiol       Date:  2016-02-01       Impact factor: 5.640

Review 5.  Bacterial toxins: Offensive, defensive, or something else altogether?

Authors:  Justine K Rudkin; Rachel M McLoughlin; Andrew Preston; Ruth C Massey
Journal:  PLoS Pathog       Date:  2017-09-21       Impact factor: 6.823

6.  Detection of opsonizing antibodies directed against a recently circulating Bordetella pertussis strain in paired plasma samples from symptomatic and recovered pertussis patients.

Authors:  Elise S Hovingh; Betsy Kuipers; Axel A Bonačić Marinović; Hendrik Jan Hamstra; Danielle Hijdra; Lapo Mughini Gras; Inonge van Twillert; Ilse Jongerius; Cecile A C M van Els; Elena Pinelli
Journal:  Sci Rep       Date:  2018-08-13       Impact factor: 4.379

Review 7.  Structure-Function Relationships Underlying the Capacity of Bordetella Adenylate Cyclase Toxin to Disarm Host Phagocytes.

Authors:  Jakub Novak; Ondrej Cerny; Adriana Osickova; Irena Linhartova; Jiri Masin; Ladislav Bumba; Peter Sebo; Radim Osicka
Journal:  Toxins (Basel)       Date:  2017-09-24       Impact factor: 4.546

Review 8.  Pathogen manipulation of host metabolism: A common strategy for immune evasion.

Authors:  Zachary Freyberg; Eric T Harvill
Journal:  PLoS Pathog       Date:  2017-12-07       Impact factor: 6.823

Review 9.  Bioengineering of Bordetella pertussis Adenylate Cyclase Toxin for Antigen-Delivery and Immunotherapy.

Authors:  Alexandre Chenal; Daniel Ladant
Journal:  Toxins (Basel)       Date:  2018-07-20       Impact factor: 4.546

10.  Functional and structural consequences of epithelial cell invasion by Bordetella pertussis adenylate cyclase toxin.

Authors:  Christelle Angely; Daniel Ladant; Emmanuelle Planus; Bruno Louis; Marcel Filoche; Alexandre Chenal; Daniel Isabey
Journal:  PLoS One       Date:  2020-05-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.